BioMarin Pharmaceutical Operating Income 2010-2024 | BMRN

BioMarin Pharmaceutical operating income for the twelve months ending September 30, 2024 was $0.322B, a 140.61% increase year-over-year.

  • BioMarin Pharmaceutical annual operating income for 2023 was $0.158B, a 5.71% increase from 2022.
  • BioMarin Pharmaceutical annual operating income for 2022 was $0.15B, a 281.64% decline from 2021.
  • BioMarin Pharmaceutical annual operating income for 2021 was $-0.082B, a 89.55% increase from 2020.

BioMarin Pharmaceutical Operating Income 2010-2024 | BMRN

  • BioMarin Pharmaceutical annual operating income for 2023 was $0.158B, a 5.71% increase from 2022.
  • BioMarin Pharmaceutical annual operating income for 2022 was $0.15B, a 281.64% decline from 2021.
  • BioMarin Pharmaceutical annual operating income for 2021 was $-0.082B, a 89.55% increase from 2020.